Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01BX003668-01A1 |
| Title: | Targeting the Melanocortin 1 Receptor by Selective Small Analogs of ?-Melanocortin for Melanoma Prevention |
| Principal Investigator: | Zalfa Abdel-Malek |
| Location: | Cincinnati, OH |
| Congressional District Code: | 1 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | April 2018 - March 2022 |
| FY 2021 Funding Amount: | $242,875 |
| Total Award Amount (all years): |
$1,154,580 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Solar ultraviolet radiation (UV) is the main etiological factor for melanoma, the deadliest form of skin cancer, and the fifth most diagnosed cancer in veterans. The incidence of melanoma is higher in veterans than in civilians, particularly in individuals with light skin color and poor tanning ability. Over 65% of all veterans have this phenotype. Deployment of millions of soldiers in geographical areas such as Iraq and Afghanistan increases their risk for melanoma due to unavoidable daily exce... |